Unitedhealth Group Inc

  • Earnings Score
  • Moat Score
  • Safety Score
  • Final Score
  • Market Cap $490.97B
  • PE 34
  • Debt $78.01B
  • Cash $32.40B
  • EV $536.58B
  • FCF $13.10B

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$14.32B
EBIT$32.20B
ROE14%
ROA11%
FCF$13.10B
Equity$99.88B
Growth Stability100%
PE34.29
PEG8.45
PB4.92
P/FCF37.49
P/S1.25
Price/Cash0.07
Debt/Equity0.78
Debt/FCF5.96
Net Margins3%
Gross Margins89%
Op. Margins8%
Earnings CAGR14%
Sales Growth YoY9%
Sales Growth QoQ2%
Sales CAGR10%
FCF CAGR10%
Equity CAGR13%
Earnings Stability0.77
Earnings Growth YoY4%
Earnings Growth QoQ44%
Earnings CAGR 5Y4%
Sales CAGR 5Y12%
FCF CAGR 5Y-4%
Equity CAGR 5Y11%
Earnings CAGR 3Y13%
Sales CAGR 3Y13%
FCF CAGR 3Y-24%
Equity CAGR 3Y11%
Market Cap$490.97B
Revenue$393.90B
Dividend Yield1%
Payout Ratio51%
Assets$299.31B
Total Debt$78.01B
Cash$32.40B
Shares Outstanding922M
EV536.58B
Earnings Score92%
Moat Score85%
Safety Score82%
Final Score86%
Working Capital-9.31B
Current Ratio0.91
Gross Profit$349.47B
Shares Growth 3y-1%
Equity Growth QoQ5%
Equity Growth YoY12%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

SEC Filings

Direct access to Unitedhealth Group Inc (UNH) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Unitedhealth Group Inc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Unitedhealth Group Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 14%
Stability 77%
loading chart...

Unitedhealth Group Inc Discounted Cash Flow

Fully customizable DCF calculator online for Unitedhealth Group Inc.

= $260B
012345678910TV
fcf$13B$14B$16B$17B$19B$21B$23B$25B$28B$31B$34B$337B
DCF$13B$13B$13B$13B$13B$13B$13B$13B$13B$13B$130B
Value$260B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins4%4%5%5%6%6%6%6%6%3%
ROA-11%11%11%11%11%11%12%12%11%
ROE-18%21%22%23%23%23%25%24%14%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-4.082.742.682.482.162.312.462.445.96
Debt over Equity0.950.860.640.670.670.640.610.710.660.78
Growth Stability---100%100%100%100%100%100%100%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-18%9%12%7%6%12%13%15%12%
Earnings YoY growth-21%50%14%15%11%12%16%11%4%
Equity YoY growth-13%31%9%11%13%10%9%16%11%
FCF YoY growth--1%43%18%20%23%-1%18%10%-4%